Moderate influenza vaccine effectiveness against A(H1N1)pdm09 virus, and low effectiveness against A(H3N2) subtype, 2018/19 season in Italy

被引：19

作者：

Bellino, Stefania ^{[1
]}

Bella, Antonino ^{[1
]}

Puzelli, Simona ^{[1
]}

Di Martino, Angela ^{[1
]}

Facchini, Marzia ^{[1
]}

Punzo, Ornella ^{[1
]}

Pezzotti, Patrizio ^{[1
]}

Castrucci, Maria Rita ^{[1
]}

Di Mario, Giuseppina ^{[2
]}

Calzoletti, Laura ^{[2
]}

Fabiani, Concetta ^{[2
]}

Chironna, Maria ^{[3
]}

Germinario, Cinzia ^{[4
]}

Tramuto, Fabio ^{[5
]}

Di Carlo, Vittorio

Affanni, Paola ^{[6
]}

Pascucci, Maria Grazia ^{[7
]}

D'Agaro, Pierlanfranco ^{[8
]}

Gallo, Tolinda ^{[9
]}

Pagani, Elisabetta ^{[10
]}

Natter, Bernhard ^{[11
]}

Camilloni, Barbara ^{[12
]}

Tosti, Anna ^{[13
]}

Pariani, Elena ^{[14
]}

Senatore, Sabrina ^{[15
]}

Serra, Caterina ^{[16
]}

Tanchis, Pierina Rita ^{[17
]}

Ghisetti, Valeria ^{[18
]}

Tiberti, Donatella ^{[19
]}

Romano, Lucio ^{[20
]}

Volpe, Enrico ^{[21
]}

Giannecchini, Simone ^{[22
]}

机构：

[1] Natl Inst Hlth, Ist Super Sanita, Dept Infect Dis, Rome, Italy

[2] ISS, Dept Infect Dis, Rome, Italy

[3] Hosp Univ Bari, Mol Epidemiol & Publ Hlth Lab, Bari, Italy

[4] Univ Bari, Dept Biomed Sci & Human Oncol, Hyg Sect, Bari, Italy

[5] Univ Palermo, Dept Hlth Promot Sci & Mother Child Care G DAless, Palermo, Italy

[6] Univ Parma, Dept Med & Surg, Parma, Italy

[7] Reg Hlth Author, Bologna, Italy

[8] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy

[9] Integrated Hlth Unit, Prevent Infect Dis Vaccinat & Travel Med, Udine, Italy

[10] Alto Adige Hlth Unit, Microbiol & Virol Lab, Bolzano, Italy

[11] Prevent Hlth Promot & Publ Hlth Off, Bolzano, Autonomous Prov, Italy

[12] Univ Perugia, Dept Med, Microbiol Unit, Perugia, Italy

[13] Reg Directorate Hlth & Welf, Perugia, Italy

[14] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy

[15] Gen Welf Directorate, Milan, Italy

[16] Univ Sassari, Dept Biomed Sci, Sassari, Italy

[17] Hyg & Hlth Promot, Cagliari, Italy

[18] Amedeo Savoia Hosp, Lab Microbiol & Virol, Turin, Italy

[19] Reg Reference Serv Epidemiol Prevent Surveillance, Alessandria, Italy

[20] Univ Cattolica Sacro Cuore, A Gemelli Univ Polyclin Fdn, Dept Lab Sci & Infect Dis, Rome, Italy

[21] Reg Directorate Integrated Hlth & Social Serv, Rome, Italy

[22] Univ Florence, Dept Expt & Clin Med, Florence, Italy

来源：

EXPERT REVIEW OF VACCINES | 2019年 / 18卷 / 11期

关键词：

Influenza vaccine effectiveness; test-negative case-control study; national influenza surveillance network; Italy; MORTALITY; EFFICACY;

D O I：

10.1080/14760584.2019.1688151

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Background: Influenza vaccines are updated every year to match the vaccine strains with currently circulating viruses; consequently influenza vaccine effectiveness (IVE) has to be assessed annually. Research design and methods: A test-negative case-control study was conducted within the context of the Italian sentinel influenza surveillance network to estimate IVE by age group, virus subtype, and vaccine brand in medically attended laboratory-confirmed influenza. Results: In Italy, the 2018/19 influenza season was characterized by the co-circulation of influenza A(H1N1)pdm09 and A(H3N2) viruses. The adjusted IVE estimate in preventing influenza was moderate (44.8%, 95% CI: 18.8 to 62.5) against A(H1N1)pdm09, whereas there was no evidence of effectiveness (1.8%, 95% CI: -37.8 to 30.1) in persons affected by A(H3N2). IVE against A(H1N1)pdm09 decreased with age ranging from 65.7% to 13.1% among children/adolescents and elderly, respectively; moreover results suggest that Vaxigrip Tetra (R) was more effective against A(H1N1)pdm09 compared to Fluarix Tetra (R) [62.5% (95% CI: 34.3 to 78.6) vs 24.5% (95% CI: -40.6 to 59.6)]. Low effectiveness (35.2%, 95% CI: -50.8 to 72.1) against A(H3N2) was detected only in the elderly immunized with Fluad (R). Conclusions: Findings suggest that influenza vaccines were low to moderately effective, probably due to a mismatch between circulating and vaccine strains.

引用

页码：1201 / 1209

页数：9

共 50 条

[41] Molecular epidemiology of influenza A(H1N1) PDM09 hemagglutinin gene circulating in Sao Paulo State, Brazil: 2016 anticipated influenza season
de Oliveira Santos, Katia Correa
Borges da Silva, Daniela Bernardes
Sasaki, Norio Augusto
Benega, Margarete Aparecida
Garten, Rebecca
de Paiva, Terezinha Maria
REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO, 2017, 59
[42] Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States
Gaglani, Manjusha
Pruszynski, Jessica
Murthy, Kempapura
Clipper, Lydia
Robertson, Anne
Reis, Michael
Chung, Jessie R.
Piedra, Pedro A.
Avadhanula, Vasanthi
Nowalk, Mary Patricia
Zimmerman, Richard K.
Jackson, Michael L.
Jackson, Lisa A.
Petrie, Joshua G.
Ohmit, Suzanne E.
Monto, Arnold S.
McLean, Huong Q.
Belongia, Edward A.
Fry, Alicia M.
Flannery, Brendan
JOURNAL OF INFECTIOUS DISEASES, 2016, 213 (10) : 1546 - 1556
[43] Database linkage for surveillance of the influenza A(H1N1)pdm09 pandemic in Brazil, 2009-2010
Rossetto, Erika Valeska
de Albuquerque Luna, Expedito Jose
CADERNOS DE SAUDE PUBLICA, 2016, 32 (07):
[44] Impact of Repeated Vaccination on Vaccine Effectiveness Against Influenza A(H3N2) and B During 8 Seasons
McLean, Huong Q.
Thompson, Mark G.
Sundaram, Maria E.
Meece, Jennifer K.
McClure, David L.
Friedrich, Thomas C.
Belongia, Edward A.
CLINICAL INFECTIOUS DISEASES, 2014, 59 (10) : 1375 - 1385
[45] Hospitalization Fatality Risk of Influenza A(H1N1)pdm09: A Systematic Reviewand Meta-Analysis
Wong, Jessica Y.
Kelly, Heath
Cheung, Chung-Mei M.
Shiu, Eunice Y.
Wu, Peng
Ni, Michael Y.
Ip, Dennis K. M.
Cowling, Benjamin J.
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2015, 182 (04) : 294 - 301
[46] Molecular and epidemiological analysis of pandemic and post-pandemic influenza A(H1N1)pdm09 virus from central India
Sahu, Mahima
Singh, Neeru
Shukla, Mohan K.
Potdar, Varhsa A.
Sharma, Ravendra K.
Sahare, Lalit Kumar
Ukey, Mahendra J.
Barde, Pradip V.
JOURNAL OF MEDICAL VIROLOGY, 2018, 90 (03) : 447 - 455
[47] Hospitalizations from pandemic Influenza [A(H1N1)pdm09] infections among type 1 and 2 diabetes patients in Spain
Jimenez-Garcia, Rodrigo
Hernandez-Barrera, Valentin
Rodriguez-Rieiro, Cristina
Lopez de Andres, Ana
de Miguel-Diez, Javier
Jimenez-Trujillo, Isabel
Gil de Miguel, Angel
Carrasco-Garrido, Pilar
INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2013, 7 (03) : 439 - 447
[48] Evaluation and sensitivity analysis of the effectiveness of unadjuvanted A(H1N1)pdm09 vaccine in hospital workers using multi-center cohort study in Korea
Lim, J.
Choi, B.
Kim, J.
Kim, J.
Kim, C.
Park, J.
Yoon, H.
Hong, S.
Seo, J.
Ki, M.
VACCINE, 2013, 31 (19) : 2381 - 2386
[49] Characteristics of Hospitalized Cases with Influenza A (H1N1) pdm09 Infection during First Winter Season of Post-Pandemic in China
Xu, Cuiling
Iuliano, A. Danielle
Chen, Min
Cheng, Po-Yung
Chen, Tao
Shi, Jinghong
Yang, Jing
Wang, Lijie
Yuan, Fan
Widdowson, Marc-Alain
Shu, Yuelong
PLOS ONE, 2013, 8 (02):
[50] Nanoparticle-Based Bivalent Swine Influenza Virus Vaccine Induces Enhanced Immunity and Effective Protection against Drifted H1N1 and H3N2 Viruses in Mice
Tang, Pan
Cui, En-hui
Chang, Wen-chi
Yu, Chen
Wang, Hao
Du, En-qi
Wang, Jing-yu
VIRUSES-BASEL, 2022, 14 (11):

← 1 2 3 4 5 →